Insiders Updates Verona Pharma Plc ADR [VRNA] Records 50-Day SMA of $15.69 Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Verona Pharma
Insiders Updates VRNA Shares Experience Decline in Value Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Verona Pharma
Analysts Viewpoint Understanding the Risks of Investing in Verona Pharma Plc ADR (VRNA) Verona Pharma Plc ADR’s recently made public that its Chief Medical Officer Rickard Kathleen A. unloaded Company’s shares for reported
Analysts Viewpoint A Guide To The Risks Of Investing In Verona Pharma Plc ADR (VRNA) Verona Pharma Plc ADR’s filing revealed that its Chief Medical Officer Rickard Kathleen A. unloaded Company’s shares for reported $80503.0